Rap1 mutants with increased affinity for the guanine-nucleotide exchange factor C3G
S. Shi, H. Kitayama, Makoto Noda
págs. 8711-8719
T. Marumoto, Dongwei Zhang, T. Hirota
págs. 8720-8730
Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis
M.-J. Wang, C.-A. Liu
págs. 8731-8742
M. L. Bowie, E. C. Dietze
págs. 8743-8755
págs. 8756-8765
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells
págs. 8766-8776
A. Chauchereau
págs. 8777-8784
págs. 8785-8795
Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines
A. Hirasawa, I. Imoto, H. Tanami
págs. 8796-8804
K. L. McGuire, J. M. Fritz, K. E. Bower
págs. 8805-8814
Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2
T. Wiederhold
págs. 8815-8825
HES-1 inhibits 17beta-estradiol and heregulin-beta1-mediated upregulation of E2F-1
J. Wimalasena, J. Hartman, J.-A. Gustafsson, J. S. Foster, P. Muller
págs. 8826-8833
I. V. Kravchenko, P. B. Kopnin
págs. 8834-8840
K. Chalitchagorn
págs. 8841-8846
Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion
M. Nesterova, C. L. Neary
págs. 8847-8856
© 2001-2024 Fundación Dialnet · Todos los derechos reservados